Clinical Trials Directory

Trials / Completed

CompletedNCT01094041

Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome

Gluten Intolerance in Irritable Bowel Syndrome With Diarrhea: The Role of HLA-DQ2

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The specific hypotheses are: Gluten supplementation for four weeks increases small intestinal permeability and accelerates colonic transit in patients with irritable bowel syndrome with diarrhea (IBS-D) or functional diarrhea (FD) who are HLA-DQ2 positive.

Detailed description

The study design is a double-blind, randomized, controlled, parallel-group, 6-week study comparing the effects of gluten rich versus gluten free diets in diarrhea or diarrhea predominant IBS patients. All participants will keep a daily bowel pattern diary throughout the study. All participants will have negative serum tissue transglutaminase (TTg) assay, and anti-endomysial antibody test, if TTg is positive or equivocal. All participants will have the following studies performed both before and after the 4-week dietary intervention: 1. Stool samples to check markers of inflammation such as fecal calprotectin. 2. Blood samples to check markers of inflammation and for genetic testing. 3. After ingestion of the mannitol, lactulose and sucralose sugars, urine samples to indirectly measure small intestinal and colonic permeability. 4. After sedation, upper gastrointestinal endoscopy and flexible sigmoidoscopy to obtain 6 mucosal biopsies from the small bowel and sigmoid colon for immunohistochemical analysis. 5. Scintigraphy to measure gastrointestinal transit.

Conditions

Interventions

TypeNameDescription
OTHERGluten free dietA 4-week gluten free diet provided
OTHERGluten rich dietA 4-week gluten rich diet is provided

Timeline

Start date
2010-02-01
Primary completion
2012-01-01
Completion
2013-01-01
First posted
2010-03-26
Last updated
2013-05-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01094041. Inclusion in this directory is not an endorsement.